|
Martínez-Martínez I, Navarro-Fernández J, Aguila S, Miñano A, Bohdan N, De La Morena-Barrio ME, Ordóñez A, Martínez C, Vicente V, Corral J. The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency. Mol Med. 2012 Jul 18;18:762-70. doi: 10.2119/molmed.2012.00017. PubMed PMID: 22481271; PubMed Central PMCID: PMC3409284.
AÑO: 2012; IF: 6.354
|
22481271
|
Martínez-Martínez I, Johnson DJ, Yamasaki M, Navarro-Fernández J, Ordóñez A, Vicente V, Huntington JA, Corral J. Type II antithrombin deficiency caused by a large in-frame insertion: structural, functional and pathological relevance. J Thromb Haemost. 2012 Sep;10(9):1859-66. doi: 10.1111/j.1538-7836.2012.04839.x. PubMed PMID: 22758787.
AÑO: 2012; IF: 6.081
|
|
Navarro-Fernández J, Pérez-Sánchez H, Martínez-Martínez I, Meliciani I, Guerrero JA, Vicente V, Corral J, Wenzel W. In silico discovery of a compound with nanomolar affinity to antithrombin causing partial activation and increased heparin affinity. J Med Chem. 2012 Jul 26;55(14):6403-12. doi: 10.1021/jm300621j. Epub 2012 Jul 17. PubMed PMID: 22742452.
AÑO: 2012; IF: 5.614
|
|
Martínez-Martínez I, Navarro-Fernández J, Østergaard A, Gutiérrez-Gallego R, Padilla J, Bohdan N, Miñano A, Pascual C, Martínez C, de la Morena-Barrio ME, Aguila S, Pedersen S, Kristensen SR, Vicente V, Corral J. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism. Blood. 2012 Jul 26;120(4):900-4. doi: 10.1182/blood-2012-01-406207. Epub 2012 Apr 12. PubMed PMID: 22498748.
AÑO: 2012; IF: 22.113
|
|
Sánchez-Guiu I, Antón AI, García-Barberá N, Navarro-Fernández J, Martínez C, Fuster JL, Couselo JM, Ortuño FJ, Vicente V, Rivera J, Lozano ML. Chediak-Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype. Eur J Haematol. 2014 Jan;92(1):49-58. doi: 10.1111/ejh.12203. PubMed PMID: 24112114.
AÑO: 2014; IF: 2.066
|